TITLE

Lymphatic Mapping Improves Staging and Reduces Morbidity in Women Undergoing Total Mastectomy for Breast Carcinoma

AUTHOR(S)
Langer, Samantha; Guenther, J. Michael; Haigh, Philip I.; Difronzo, L. Andrew
PUB. DATE
October 2004
SOURCE
American Surgeon;Oct2004, Vol. 70 Issue 10, p881
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Lymphatic mapping (LM) and sentinel lymph node biopsy (SLNB) have become widely accepted in the setting of breast conservation surgery. We hypothesized that LM can be extended to women undergoing total mastectomy, being technically feasible, yielding highly accurate and sensitive results, improving axillary staging, and reducing postoperative morbidity. Between 1995 and 2003, 99 women (mean age 59 years, range 34-87) underwent 100 mastectomies with LM using blue dye alone. Fifty-nine operations (60%) were followed by a completion axillary lymph node dissection (ALND). Ninety per cent of patients had invasive carcinoma; 10 per cent had in situ carcinoma. Mean tumor size was 2.5 cm (range 0.3-8 cm). One hundred fifty-nine sentinel nodes (SNs) (mean 1.65, range 1-5) were successfully identified in 96 (96%) axillae. Twenty-five (25%) sentinel nodes revealed nodal metastases. Five of 25 (20%) SNs had micrometasteses. Three patients had a false-negative SN, yielding a sensitivity of 91 per cent. The accuracy of LM was 97 per cent. No patient who underwent SLNB alone developed lymphedema, axillary seroma formation, infection, or restricted arm movement. This was contrasted with patients undergoing ALND, where 10 (16%) developed lymphedema and 2 (3%) developed an infection. Ten (25%) patients developed axillary paresthesias after SNB compared with 47 (78%) patients after ALND (P < 0.0001). LM in the setting of mastectomy is accurate and sensitive. This technique improves axillary staging and decreases morbidity. Patients who are not candidates for breast conservation should be offered LM and SLNB at the time of mastectomy.
ACCESSION #
14698133

 

Related Articles

  • Perfonning Lymph Node Biopsy Earlier.  // USA Today Magazine;Feb2006, Vol. 134 Issue 2729, p11 

    The article reports that altering the standard step-by-step mastectomy can improve the process and help determine if immediate reconstruction is the best course of action, according to research from the University of North Carolina in Chapel Hill. The use of sentinel lymph node biopsy (SLNB) is...

  • Effect On Oximetry Of Isosulfan Blue Used For Sentinel Lymph Node Biopsy In Breast Surgery. Turkmen, Aygen; Turgut, Namigar; Guven, Hakan; Ulufi, Nalan; Altan, Aysel; Ali, Achmet; Alkan, Irem // Internet Journal of Anesthesiology;2008, Vol. 15 Issue 2, p2 

    Isosulfan blue 1% is a dye used in medical procedures such as lymphangiography and sentinel lymph node biopsy. Besides anaphylaxis, isosulfan blue dye may cause discoloration of a patient's serum making the use of pulse oximetry useless by mimicking true intraoperative hypoxia. A 70-year old...

  • Impact of Sentinel Lymph Node Biopsy on Immediate Breast Reconstruction after Mastectomy. WOOD, BENJAMIN C.; DAVID, LISA R.; DEFRANZO, ANTHONY J.; STEWART, JOHN H.; SHEN, PERRY; GEISINGER, KIM R.; MARKS, MALCOLM W.; LEVINE, EDWARD A. // American Surgeon;Jul2009, Vol. 75 Issue 7, p551 

    Traditionally, sentinel lymph node biopsy (SLNB) is performed at the time of mastectomy and reconstruction. However, several groups have advocated SLNB as a separate outpatient procedure before mastectomy, when immediate reconstruction is planned, to allow for complete pathologic evaluation. The...

  • Management of Axillary Lymph Node Metastasis in Breast Cancer: Making Progress. Carlson, Grant Walter; Wood, William C. // JAMA: Journal of the American Medical Association;2/9/2011, Vol. 305 Issue 6, p606 

    The article examines developments in the management of axillary lymph node metastasis in breast cancer. Halsted radical mastectomy, which involved removal of the breast, the adjacent musculature and axillary lymph nodes, has been the standard treatment for breast cancer. In the National Surgical...

  • Re-sentinel node biopsy after previous breast and axillary surgery. Ikeda, Tadashi // Surgery Today;Nov2014, Vol. 44 Issue 11, p2015 

    There is no consensus regarding the strategy for managing the regional lymph nodes in patients with local breast cancer recurrence. This paper reviews the updated data on re-sentinel lymph node biopsy (re-SLNB) after previous surgery. The identification rate of re-SLNB varied from 29 to 100 %...

  • Axillary sentinel lymph node biopsy after mastectomy: a case report. Vicente, Diego A.; Henry, Leonard R.; Hahm, George; Soballe, Peter W.; Smart, DeeDee // World Journal of Surgical Oncology;2010, Vol. 8, p59 

    Background: Sentinel lymph node biopsy has been established as the preferred method for staging early breast cancer. A prior history of mastectomy is felt to be a contraindication. Case presentation: A patient with recurrent breast cancer in her skin flap was discovered to have positive axillary...

  • Clinical relevance of sentinel lymph nodes in the internal mammary chain in breast cancer patients. Paredes, Pilar; Vidal-Sicart, Sergi; Zanón, Gabriel; Pahisa, Jaume; Fernández, Pedro Luís; Velasco, Martín; Santamaría, Gorane; Ortín, Jaime; Duch, Joan; Pons, Francesca // European Journal of Nuclear Medicine & Molecular Imaging;Nov2005, Vol. 32 Issue 11, p1283 

    Purpose: Despite the widespread use of sentinel lymph node (SLN) biopsy in breast cancer patients, some controversy exists about the correct management of extra-axillary nodes, especially those located in the internal mammary chain. The aim of this study was to evaluate the incidence of SLNs in...

  • Unnecessary mastectomy: $6.5 million verdict in NY. Bachman, Radha V.; Reding, Barbara // Same-Day Surgery;Nov2009, Vol. 33 Issue 11, p112 

    A woman underwent an excisional biopsy on her left breast. The physician who performed the surgery diagnosed cancer and began chemotherapy. Later, other physicians evaluated the woman and recommended a mastectomy and removal of lymph nodes in the woman's breast. • After the mastectomy, no...

  • Complete axillary conversion after neoadjuvant chemotherapy in locally advanced breast cancer: a step towards conserving axilla? Arimappamagan, A.; Kadambari, D.; Srinivasan, K.; Krishnan, R.; Elangovan, S.; Reddy, K.S.N. // Indian Journal of Cancer;Jan-Mar2004, Vol. 41 Issue 1, p13 

    Objectives: This study was designed to assess the clinical, sonographic and histopathological response of axillary lymph node metastasis to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Material and Methods: Forty patients with locally...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics